RETRACTED: Continuous G-CSF therapy for isolated chronic mucocutaneous candidiasis: Complete clinical remission with restoration of IL-17 secretion (Journal of Allergy and Clinical Immunology (2013) 132(3) (761–764) (S0091674913006659) (10.1016/j.jaci.2013.04.018));Continuous G-CSF therapy for isolated chronic mucocutaneous candidiasis: Complete clinical remission with restoration of IL-17 secretion

Journal of Allergy and Clinical Immunology

Volumn 132, Issue 3, 2013, Pages 761-764

  Wildbaum, Gizi ^a   Shahar, Eduardo ^a,b   Katz, Rina ^b   Karin, Nathan ^a   Etzioni, Amos ^a,b   Pollack, Shimon ^a,b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b Ctr for Implant Surgery   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 27; INTERLEUKIN 6; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; STAT1 PROTEIN; STAT3 PROTEIN;

ADULT; CANDIDA ALBICANS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DIABETES MELLITUS; FEMALE; GENE MUTATION; HUMAN; LETTER; LEUKOCYTE COUNT; MONOCYTE; MUCOCUTANEOUS CANDIDIASIS; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMISSION; TH17 CELL; TREATMENT RESPONSE;

EID: 84883238238     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2018.01.002     Document Type: Erratum

References (10)

1. S. Hanna, and A. Etzioni New host defense mechanisms against Candida species clarify the basis of clinical phenotypes J Allergy Clin Immunol 127 2011 1433 1437
2. C.E. Zielinski, F. Mele, D. Aschenbrenner, D. Jarrossay, F. Ronchi, and M. Gattorno Pathogen- induced human TH-17 cells produce IFN-γ or IL-10 and are regulated by IL-1β Nature 484 2012 514 518
3. J. Milner, J.M. Brenchley, A. Laurence, A.F. Freeman, B.J. Hill, and K.M. Elias Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome Nature 452 2008 773 776
4. A. Puel, R. Doffinger, A. Natividad, M. Chrabeih, G. Barcenas-Morales, and C. Picard Autoantibodies against IL-17A, IL-17F and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type 1 J Exp Med 207 2010 291 297
5. L. Liu, S. Okada, X.F. Kong, A.Y. Kreins, S. Cypowyj, and A. Abhyankar Gain of function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis J Exp Med 208 2011 1635 1648
6. E. Shahar, N. Kriboy, and S. Pollack White cell enhancement in the treatment of severe candidosis Lancet 346 1995 974 975
7. M.J. McGeachy GM-CSF: the secret weapon in the TH17 arsenal Nat Immunol 12 2011 521 522
8. S.S. Tian, P. Lamb, H.M. Seidel, R.B. Stein, and J. Rosen Rapid activation of the STAT3 transcription factor by granulocyte-colony stimulating factor Blood 84 1994 1760 1764
9. S. Cypowyj, C. Piccard, L. Marodi, J.L. Casanova, and A. Puel Immunity to infection in IL17 deficiency mice and humans Eur J Immunol 42 2012 2246 2254
10. T. Tamiya, I. Kashiwagi, R. Takahashi, H. Yasukawa, and A. Yoshimura Suppressors of cytokine signaling (SOCS) proteins and JAK/STAT pathways: regulation of T-cell inflammation by SOCS1 and SOCS3 Arterioscler Thromb Vasc Biol 2012 981 985